Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057370003> ?p ?o ?g. }
- W2057370003 endingPage "1741" @default.
- W2057370003 startingPage "1733" @default.
- W2057370003 abstract "ObjectiveTo study the effect of growth hormone (GH) treatment on ovarian and uterine morphology and function in short, prepubertal small-for-gestational-age (SGA) girls.DesignA multinational, randomized controlled trial on safety and efficacy of GH therapy in short, prepubertal children born SGA.SettingNot applicable.Patient(s)A subgroup of 18 Danish girls born SGA included in North European SGA Study (NESGAS).Intervention(s)One year of GH treatment (67 μg/kg/day) followed by 2 years of randomized GH treatment (67 μg/kg/day, 35 μg/kg/day, or IGF-I titrated).Main Outcome Measure(s)Data on anthropometrics, reproductive hormones, and ultrasonographic examination of the internal genitalia were collected during 36 months of GH treatment.Result(s)Uterine and ovarian volume increased significantly during 3 years of treatment (64% and 110%, respectively) but remained low within normal reference ranges. Ovarian follicles became visible in 58% after 1 year compared with 28% before GH therapy. Anti-Müllerian hormone increased significantly during the 3 years of GH therapy but remained within the normal range. Precocious puberty was observed in one girl; another girl developed multicystic ovaries.Conclusion(s)GH treatment was associated with statistically significant growth of the internal genitalia, but remained within the normal range. As altered pubertal development and ovarian morphology were found in 2 of 18 girls, monitoring of puberty and ovarian function during GH therapy in SGA girls is prudent. Altogether, the findings are reassuring. However, long-term effects of GH treatment on adult reproductive function remain unknown.Clinical Trial Registration NumberEudraCT 2005-001507-19. To study the effect of growth hormone (GH) treatment on ovarian and uterine morphology and function in short, prepubertal small-for-gestational-age (SGA) girls. A multinational, randomized controlled trial on safety and efficacy of GH therapy in short, prepubertal children born SGA. Not applicable. A subgroup of 18 Danish girls born SGA included in North European SGA Study (NESGAS). One year of GH treatment (67 μg/kg/day) followed by 2 years of randomized GH treatment (67 μg/kg/day, 35 μg/kg/day, or IGF-I titrated). Data on anthropometrics, reproductive hormones, and ultrasonographic examination of the internal genitalia were collected during 36 months of GH treatment. Uterine and ovarian volume increased significantly during 3 years of treatment (64% and 110%, respectively) but remained low within normal reference ranges. Ovarian follicles became visible in 58% after 1 year compared with 28% before GH therapy. Anti-Müllerian hormone increased significantly during the 3 years of GH therapy but remained within the normal range. Precocious puberty was observed in one girl; another girl developed multicystic ovaries. GH treatment was associated with statistically significant growth of the internal genitalia, but remained within the normal range. As altered pubertal development and ovarian morphology were found in 2 of 18 girls, monitoring of puberty and ovarian function during GH therapy in SGA girls is prudent. Altogether, the findings are reassuring. However, long-term effects of GH treatment on adult reproductive function remain unknown." @default.
- W2057370003 created "2016-06-24" @default.
- W2057370003 creator A5000203104 @default.
- W2057370003 creator A5000864311 @default.
- W2057370003 creator A5005770292 @default.
- W2057370003 creator A5015033910 @default.
- W2057370003 creator A5021689410 @default.
- W2057370003 creator A5032061636 @default.
- W2057370003 creator A5033057812 @default.
- W2057370003 creator A5045917807 @default.
- W2057370003 creator A5058214867 @default.
- W2057370003 creator A5058299236 @default.
- W2057370003 creator A5065313744 @default.
- W2057370003 creator A5067208466 @default.
- W2057370003 creator A5070544566 @default.
- W2057370003 creator A5085924615 @default.
- W2057370003 creator A5087251514 @default.
- W2057370003 date "2014-12-01" @default.
- W2057370003 modified "2023-09-26" @default.
- W2057370003 title "Ovarian morphology and function during growth hormone therapy of short girls born small for gestational age" @default.
- W2057370003 cites W1966881991 @default.
- W2057370003 cites W1977801566 @default.
- W2057370003 cites W1981296559 @default.
- W2057370003 cites W1982575480 @default.
- W2057370003 cites W1987412849 @default.
- W2057370003 cites W1992363213 @default.
- W2057370003 cites W1992452077 @default.
- W2057370003 cites W1993721330 @default.
- W2057370003 cites W1995686552 @default.
- W2057370003 cites W1996581182 @default.
- W2057370003 cites W2003583785 @default.
- W2057370003 cites W2005488131 @default.
- W2057370003 cites W2006415706 @default.
- W2057370003 cites W2012417810 @default.
- W2057370003 cites W2015838103 @default.
- W2057370003 cites W2041411479 @default.
- W2057370003 cites W2045437647 @default.
- W2057370003 cites W2061595117 @default.
- W2057370003 cites W2064252858 @default.
- W2057370003 cites W2080172457 @default.
- W2057370003 cites W2085490384 @default.
- W2057370003 cites W2086664003 @default.
- W2057370003 cites W2087503102 @default.
- W2057370003 cites W2090353021 @default.
- W2057370003 cites W2090489384 @default.
- W2057370003 cites W2094831681 @default.
- W2057370003 cites W2107615221 @default.
- W2057370003 cites W2109198568 @default.
- W2057370003 cites W2117364932 @default.
- W2057370003 cites W2123780587 @default.
- W2057370003 cites W2124380228 @default.
- W2057370003 cites W2127354245 @default.
- W2057370003 cites W2130933461 @default.
- W2057370003 cites W2140380690 @default.
- W2057370003 cites W2149458583 @default.
- W2057370003 cites W2162206900 @default.
- W2057370003 cites W2162306659 @default.
- W2057370003 cites W2166229423 @default.
- W2057370003 cites W2166969733 @default.
- W2057370003 cites W2168694309 @default.
- W2057370003 cites W2171589158 @default.
- W2057370003 cites W4253299530 @default.
- W2057370003 doi "https://doi.org/10.1016/j.fertnstert.2014.09.014" @default.
- W2057370003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25439809" @default.
- W2057370003 hasPublicationYear "2014" @default.
- W2057370003 type Work @default.
- W2057370003 sameAs 2057370003 @default.
- W2057370003 citedByCount "7" @default.
- W2057370003 countsByYear W20573700032015 @default.
- W2057370003 countsByYear W20573700032017 @default.
- W2057370003 countsByYear W20573700032019 @default.
- W2057370003 countsByYear W20573700032020 @default.
- W2057370003 countsByYear W20573700032021 @default.
- W2057370003 countsByYear W20573700032023 @default.
- W2057370003 crossrefType "journal-article" @default.
- W2057370003 hasAuthorship W2057370003A5000203104 @default.
- W2057370003 hasAuthorship W2057370003A5000864311 @default.
- W2057370003 hasAuthorship W2057370003A5005770292 @default.
- W2057370003 hasAuthorship W2057370003A5015033910 @default.
- W2057370003 hasAuthorship W2057370003A5021689410 @default.
- W2057370003 hasAuthorship W2057370003A5032061636 @default.
- W2057370003 hasAuthorship W2057370003A5033057812 @default.
- W2057370003 hasAuthorship W2057370003A5045917807 @default.
- W2057370003 hasAuthorship W2057370003A5058214867 @default.
- W2057370003 hasAuthorship W2057370003A5058299236 @default.
- W2057370003 hasAuthorship W2057370003A5065313744 @default.
- W2057370003 hasAuthorship W2057370003A5067208466 @default.
- W2057370003 hasAuthorship W2057370003A5070544566 @default.
- W2057370003 hasAuthorship W2057370003A5085924615 @default.
- W2057370003 hasAuthorship W2057370003A5087251514 @default.
- W2057370003 hasConcept C126322002 @default.
- W2057370003 hasConcept C134018914 @default.
- W2057370003 hasConcept C2778135454 @default.
- W2057370003 hasConcept C2778324911 @default.
- W2057370003 hasConcept C2778376644 @default.
- W2057370003 hasConcept C2779234561 @default.
- W2057370003 hasConcept C2780938740 @default.
- W2057370003 hasConcept C2984496839 @default.